Suppr超能文献

抗体类生物治疗候选药物亲和力成熟的结构考虑因素。

Structural Considerations in Affinity Maturation of Antibody-Based Biotherapeutic Candidates.

机构信息

Computational Biochemistry and Bioinformatics Group, Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.

Scientific Services Manager, Biologics, Chemical Computing Group ULC, Montreal, QC, Canada.

出版信息

Methods Mol Biol. 2023;2552:309-321. doi: 10.1007/978-1-0716-2609-2_17.

Abstract

Affinity maturation is an important stage in biologic drug discovery as is the natural process of generating an immune response inside the human body. In this chapter, we describe in silico approaches to affinity maturation via a worked example. Both advantages and limitations of the computational methods used are critically examined. Furthermore, construction of affinity maturation libraries and how their outputs might be implemented in an experimental setting are also described. It should be noted that structure-based design of biologic drugs is an emerging field and the tools currently available require further development. Furthermore, there are no standardized structure-based strategies yet for antibody affinity maturation as this research relies heavily on scientific logic as well as creative intuition.

摘要

亲和力成熟是生物药物发现的一个重要阶段,也是人体内产生免疫反应的自然过程。在本章中,我们通过一个实例描述了通过计算机模拟进行亲和力成熟的方法。批判性地检查了所使用的计算方法的优缺点。此外,还描述了亲和力成熟文库的构建以及如何在实验环境中实施它们的输出。应该注意的是,生物药物的基于结构的设计是一个新兴领域,目前可用的工具需要进一步开发。此外,由于该研究严重依赖于科学逻辑和创造性直觉,因此还没有用于抗体亲和力成熟的标准化基于结构的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验